Vanta Bioscience Ltd to Approve Unaudited Financial Results for H1 FY2025-26 on Nov 14, 2025

Vanta Bioscience Ltd has scheduled a Board of Directors meeting on November 14, 2025, to consider and approve the Unaudited financial results for the half year ended September 30, 2025. The meeting will also take note of the limited review report of the statutory auditors. The trading window for all designated persons under the Insider Trading Policy of the Company is closed from October 01, 2025, till November 16, 2025 (both days inclusive).